Axogen, INC Schedule 13G passive stakes

First Light Asset Management, LLC and Mathew P. Arens report increased beneficial ownership of Axogen, Inc. common stock, now holding approximately 7.58%.

Vanguard Capital Management has disclosed a beneficial ownership of 4.99% in Axogen Inc., holding 2,654,445 shares as of June 30, 2026.

First Light Asset Management and Mathew P. Arens report a combined beneficial ownership of 6.8% of Axogen Inc. common stock as of April 30, 2026.

Vanguard Capital Management reports beneficial ownership of over 2.6 million shares, representing 5.12% of Axogen Inc.'s common stock.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Axogen Inc. following an internal corporate realignment.

First Light Asset Management and Mathew P. Arens have increased their beneficial ownership in Axogen, Inc., now holding 12.24% and 12.88% respectively.

ArrowMark Colorado Holdings, LLC has filed an Amendment No. 9 to its Schedule 13G, disclosing a 3.59% beneficial ownership stake in Axogen, Inc. as of March 31, 2025.

Soleus Capital Master Fund, L.P. and its affiliated entities, including Guy Levy, have filed an Amendment No. 3 to their Schedule 13G, disclosing a continued beneficial ownership of 3.7% in Axogen, Inc. common stock as of March 31, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G for Axogen, Inc., disclosing a 5.3% beneficial ownership by Morgan Stanley, while Morgan Stanley Capital Services LLC has ceased to be a beneficial owner of more than five percent of the common stock.

First Light Asset Management, LLC and its managing member, Mathew P. Arens, have disclosed a passive beneficial ownership of 10.51% in Axogen, Inc. common stock.